⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

CDNA

CareDx, Inc.

Healthcare · Diagnostics & Research

50.03USD

-0.2800 (-0.56%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 50.03
P/E23.4
Dvd Ind Yld—
P/B6.12
P/S5.7
Curr EV/T12M EBITDA18.6
Mkt Cap (USD)2.6B
Curr EV (USD)2.3B
2)

Per Share Data

EPS T12M2.07
DPS—
Bk Val Per Sh8.27
Rev/Sh8.57
Cash/Sh7.22
Curr Shares Out51.7M
FCF/Sh0.19
3)

Cash Flow Analysis

P/CF27.8
Curr P/FCF262.0
CF/NI0.8
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales20.4%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr-143.0%
Cap 1Y Gr-19.9%
BPS 1Y Gr-14.9%
R&D To Sales17.4%
Retention Rate100.0%
Rev 1Y Gr13.8%
FCF 1Y Gr58.3%
Assets 1Y Gr-15.8%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin23.6%
Pretax Margin25.1%
Net Margin24.2%
ROA22.7%
ROE29.5%
ROC24.5%
Asset Turnover0.94
6)

Structure

Current Ratio4.58
Quick Ratio4.36
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA-3.05
Tot Debt/Capital0.0%
Gross Margin21.4%
EBIT/Int Exp67.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.